Evidence map›Paper›PMID 33893911›Full record

ReviewNeurochemical research2022

Rapid Regulation of Glutamate Transport: Where Do We Go from Here?

Alain M Guillem, Elizabeth N Krizman, Michael B Robinson

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Palmitoylation of solute carriers.Biochemical pharmacology · 2023
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alain M GuillemDepartment of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, 19104-4318, USA.ORCID http://orcid.org/0000-0002-0712-7392
Elizabeth N KrizmanDepartment of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, 19104-4318, USA.
Michael B RobinsonDepartment of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, 19104-4318, USA. robinson@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0003-0162-2218
Children's Hospital of Philadelphia · US

Funding

Astroglial Glutamate Transporters, Calcium, and MitochondriaR01NS106693 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBINSON, MICHAEL BYRNE · 2018 to 2021
$2.0M
Astroglial Glutamate Transporters, Energetics, and MitochondriaR01NS077773 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBINSON, MICHAEL BYRNE · 2012 to 2015
$1.4M
NINDS NIH HHS R01 NS077773NINDS NIH HHS R01 NS106693
6 · The paper itself

Abstract

Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system (CNS). A family of five Na

Indexed as

Amino Acid Transport System X-AGGlutamic AcidAnimalsCentral Nervous SystemExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2HumansMammalsSodiumSynaptosomesAmino Acid Transport System X-AGExcitatory Amino Acid Transporter 1Excitatory Amino Acid Transporter 2Glutamic AcidSodiumEAAC1Excitatory amino acid transporterGLASTGLT-1Glutamate transportProtein kinase C

Identifiers

PMID33893911
PMCPMC8542062
OpenAlexW3153808861

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.